Management of Facial Nerve Paresis After Nerve-Preserving Parotidectomy: A Review
Journal of Clinical Medicine · 29.10.2026 · 15 (21) · 8417
DOI: 10.3390/jcm15218417 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.10.2026. Verfasst von Fabio Maglitto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Maxillofacial Surgery Unit, Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, 80131 Napl…. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Postoperative facial nerve paresis remains clinically relevant after nerve-preserving parotidectomy. This scoping review aimed to identify, map, and characterize reported therapeutic strategies and summarize clinical recovery outcomes.
Methods
Following Joanna Briggs Institute guidance and PRISMA-ScR, the protocol was deposited on Figshare before data extraction. PubMed, Embase, and Scopus were searched through 24 August 2026. English-language original studies of treatments initiated after the recognition of paresis were eligible. Two reviewers independently selected and appraised studies; one reviewer charted the data and another verified the extraction.
Results
Eight studies involving 211 patients were included; reported ages were 17–86 years. Procedures included partial, superficial, subtotal, total, and revision parotidectomy, as well as parotid lobectomy for benign or malignant disease. Immediate or early weakness predominated; two reports described delayed-onset palsy. Evidence comprised two randomized trials, one case–control study, one multicenter cohort, and four case reports. Interventions included corticosteroids, corticosteroid–antiviral therapy, home or supervised exercises, Kabat rehabilitation, neuromuscular retraining, Matrix Rhythm Therapy (MRT), and proprioceptive neuromuscular facilitation with electrical stimulation. The trials found no benefit of prednisolone over placebo and no statistically significant difference between supervised rehabilitation and home exercises; equivalence was not established. Observational findings could not be separated from spontaneous recovery or co-treatment.
Conclusions
No intervention has established superiority. Standardized protocols, validated outcomes, and adequately powered comparative studies are needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Maxillofacial Surgery Unit, Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, 80131 Naples, Italy.
- Department of Life Science, Health and Health Professions, Università Degli Studi "Link", 00165 Rome, Italy.
- Department of Maxillofacial Surgery, "S. Maria" Hospital, 05100 Terni, Italy.
- Maxillofacial Surgery Unit, University Hospital of Sassari, 07100 Sassari, Italy.
ORCID-Profile: Giovanni Salzano, Serena Trotta, Eutilia Manzo, Valentino Vellone, Umberto Committeri, Luigi Angelo Vaira, Giovanni Dell'Aversana Orabona
Zitieren
APA
Maglitto, F., Salzano, G., Trotta, S., Manzo, E., Vellone, V., Committeri, U., Vaira, L. A., & Dell'Aversana Orabona, G. (2026). Management of Facial Nerve Paresis After Nerve-Preserving Parotidectomy: A Review. Journal of Clinical Medicine, 15(21), 8417. https://doi.org/10.3390/jcm15218417
Vancouver
Maglitto F, Salzano G, Trotta S, Manzo E, Vellone V, Committeri U, et al. Management of Facial Nerve Paresis After Nerve-Preserving Parotidectomy: A Review. Journal of Clinical Medicine. 2026;15(21):8417. doi:10.3390/jcm15218417
BibTeX
@article{Maglitto2026,
author = {Maglitto, Fabio and Salzano, Giovanni and Trotta, Serena and Manzo, Eutilia and Vellone, Valentino and Committeri, Umberto and Vaira, Luigi Angelo and Dell'Aversana Orabona, Giovanni},
title = {Management of Facial Nerve Paresis After Nerve-Preserving Parotidectomy: A Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8417},
doi = {10.3390/jcm15218417}
}
EUVIMED